Duesburg Appeals

The article titled 230 Publication Of AIDS Article Spurs Debate Over Peer Review” (The Scientist, April 3, 1989, page 1), described the scrutiny that my thesis—that HIV is not the cause of AIDS— was subjected to prior to its publication in PNAS (86:755-64, 1989). This report was accurate, fair, and open. However, I was disappointed to read that retrovirologists Howard Temin and Harold Ginsberg stated to The Scientist that my article “still contained errors,” despite

Written byPeter Duesberg
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

The article titled 230 Publication Of AIDS Article Spurs Debate Over Peer Review” (The Scientist, April 3, 1989, page 1), described the scrutiny that my thesis—that HIV is not the cause of AIDS— was subjected to prior to its publication in PNAS (86:755-64, 1989). This report was accurate, fair, and open. However, I was disappointed to read that retrovirologists Howard Temin and Harold Ginsberg stated to The Scientist that my article “still contained errors,” despite seven reviews, including three anonymous ones. Since I like nothing more than to correct my own errors—particularly when they concern such an important subject as AIDS—I have written to both Temin and Ginsberg, asking them to please identify these errors. Temin responded to the two letters I sent him by saying he had no time to identify these errors, and Ginsberg did not reply at all. I herein repeat my request that Temin and Ginsberg ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies